Achieve Life Sciences Inc (NAS:ACHV)
$ 4.71 0.06 (1.29%) Market Cap: 161.75 Mil Enterprise Value: 116.02 Mil PE Ratio: 0 PB Ratio: 3.83 GF Score: 41/100

Achieve Life Sciences Inc Phase 2 ORCA-V1 Trial Results Call Transcript

Apr 20, 2023 / 12:30PM GMT
Release Date Price: $6.8 (-3.00%)
Operator

Greetings, and welcome to the Achieve Life Sciences ORCA-V1 Top Line Clinical Trial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Jaime Xinos, Executive Vice President of Achieve. Please go ahead.

Jaime Xinos
Achieve Life Sciences, Inc. - EVP of Commercial

Thank you, operator, and thank you to everyone for joining the call. Today from achieve, we have John Bencich, Chief Executive Officer; Dr. Cindy Jacobs, President and Chief Medical Officer; and Rick Stewart, Achieve Co-Founder and Chairman of the Board of Directors.

I'd like to remind everyone that today's conference call contains forward-looking statements based on current expectations. These statements are only predictions, and actual results may vary materially from those projected. Please refer to Achieve documents available on our website and filed with the SEC concerning factors that could affect the company.

I will now turn the call over to John.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot